Novartis Pharma S.p.A. (manufacturing according to full cycle)
UkraineAll drugs from this manufacturer
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if this condition cannot be controlled using a single component (amlodipine or valsartan) alone.
Dosage form: tablets, film-coated
Active substance Dosage amlodipine 5 mg valsartan 160 mg ATC: C09DB01
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults if this condition cannot be controlled by using a single component (amlodipine or valsartan) alone.
Dosage form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 160 mg ATC: C09DB01
-
The drug is intended for the treatment of essential hypertension in adults whose blood pressure is adequately controlled by a combination of individual drugs or combination products.
Dosage form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 160 mg hydrochlorothiazide 25 mg ATC: C09DX01
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by a combination of other drugs.
Dosage form: tablets, film-coated
Active substance Dosage amlodipine 10 mg valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DX01
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults whose blood pressure is not controlled by a combination of other drugs.
Dosage form: tablets, film-coated
Active substance Dosage amlodipine 5 mg valsartan 160 mg hydrochlorothiazide 12.5 mg ATC: C09DX01